vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and National Energy Services Reunited Corp. (NESR). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $295.3M, roughly 1.7× National Energy Services Reunited Corp.). National Energy Services Reunited Corp. runs the higher net margin — 6.0% vs -10.1%, a 16.1% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -12.2%). National Energy Services Reunited Corp. produced more free cash flow last quarter ($-34.1M vs $-69.0M).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

National Energy Services Reunited Corp. is a leading integrated oilfield services provider offering a full suite of solutions covering well construction, completion, production, and intervention services for upstream oil and gas operators. Its core markets cover the Middle East, North Africa, and East Asia, serving both national oil companies and international energy clients.

CLOV vs NESR — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.7× larger
CLOV
$487.7M
$295.3M
NESR
Growing faster (revenue YoY)
CLOV
CLOV
+56.9% gap
CLOV
44.7%
-12.2%
NESR
Higher net margin
NESR
NESR
16.1% more per $
NESR
6.0%
-10.1%
CLOV
More free cash flow
NESR
NESR
$34.9M more FCF
NESR
$-34.1M
$-69.0M
CLOV

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CLOV
CLOV
NESR
NESR
Revenue
$487.7M
$295.3M
Net Profit
$-49.3M
$17.7M
Gross Margin
12.0%
Operating Margin
-10.1%
6.6%
Net Margin
-10.1%
6.0%
Revenue YoY
44.7%
-12.2%
Net Profit YoY
-123.2%
-14.0%
EPS (diluted)
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
NESR
NESR
Q4 25
$487.7M
Q3 25
$496.6M
$295.3M
Q2 25
$477.6M
$327.4M
Q1 25
$462.3M
$303.1M
Q4 24
$337.0M
Q3 24
$331.0M
$336.2M
Q2 24
$356.3M
$325.0M
Q1 24
$346.9M
Net Profit
CLOV
CLOV
NESR
NESR
Q4 25
$-49.3M
Q3 25
$-24.4M
$17.7M
Q2 25
$-10.6M
$15.2M
Q1 25
$-1.3M
$10.4M
Q4 24
$-22.1M
Q3 24
$-9.2M
$20.6M
Q2 24
$7.4M
$18.9M
Q1 24
$-19.2M
Gross Margin
CLOV
CLOV
NESR
NESR
Q4 25
Q3 25
12.0%
Q2 25
13.4%
Q1 25
12.4%
Q4 24
Q3 24
24.5%
15.9%
Q2 24
30.3%
16.4%
Q1 24
23.6%
Operating Margin
CLOV
CLOV
NESR
NESR
Q4 25
-10.1%
Q3 25
-4.9%
6.6%
Q2 25
-2.2%
8.3%
Q1 25
-0.3%
6.9%
Q4 24
-6.4%
Q3 24
-2.7%
10.5%
Q2 24
2.0%
10.5%
Q1 24
-6.5%
Net Margin
CLOV
CLOV
NESR
NESR
Q4 25
-10.1%
Q3 25
-4.9%
6.0%
Q2 25
-2.2%
4.6%
Q1 25
-0.3%
3.4%
Q4 24
-6.6%
Q3 24
-2.8%
6.1%
Q2 24
2.1%
5.8%
Q1 24
-5.5%
EPS (diluted)
CLOV
CLOV
NESR
NESR
Q4 25
Q3 25
$0.18
Q2 25
$0.16
Q1 25
$0.11
Q4 24
Q3 24
$0.22
Q2 24
$0.20
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
NESR
NESR
Cash + ST InvestmentsLiquidity on hand
$78.3M
$69.7M
Total DebtLower is stronger
$274.1M
Stockholders' EquityBook value
$308.7M
$956.7M
Total Assets
$541.0M
$1.8B
Debt / EquityLower = less leverage
0.29×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
NESR
NESR
Q4 25
$78.3M
Q3 25
$69.7M
Q2 25
$131.8M
Q1 25
$78.7M
Q4 24
$194.5M
Q3 24
$288.0M
$118.2M
Q2 24
$254.8M
$75.0M
Q1 24
$208.3M
Total Debt
CLOV
CLOV
NESR
NESR
Q4 25
Q3 25
$274.1M
Q2 25
$291.7M
Q1 25
$309.2M
Q4 24
Q3 24
$358.7M
Q2 24
$376.7M
Q1 24
Stockholders' Equity
CLOV
CLOV
NESR
NESR
Q4 25
$308.7M
Q3 25
$340.9M
$956.7M
Q2 25
$344.2M
$936.9M
Q1 25
$336.1M
$920.5M
Q4 24
$341.1M
Q3 24
$342.2M
$873.5M
Q2 24
$324.9M
$851.4M
Q1 24
$292.5M
Total Assets
CLOV
CLOV
NESR
NESR
Q4 25
$541.0M
Q3 25
$559.7M
$1.8B
Q2 25
$575.0M
$1.8B
Q1 25
$583.7M
$1.8B
Q4 24
$580.7M
Q3 24
$653.0M
$1.8B
Q2 24
$674.2M
$1.8B
Q1 24
$671.8M
Debt / Equity
CLOV
CLOV
NESR
NESR
Q4 25
Q3 25
0.29×
Q2 25
0.31×
Q1 25
0.34×
Q4 24
Q3 24
0.41×
Q2 24
0.44×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
NESR
NESR
Operating Cash FlowLast quarter
$-66.9M
$6.7M
Free Cash FlowOCF − Capex
$-69.0M
$-34.1M
FCF MarginFCF / Revenue
-14.1%
-11.5%
Capex IntensityCapex / Revenue
0.4%
13.8%
Cash ConversionOCF / Net Profit
0.38×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$68.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
NESR
NESR
Q4 25
$-66.9M
Q3 25
$12.1M
$6.7M
Q2 25
$5.4M
$98.5M
Q1 25
$-16.3M
$20.5M
Q4 24
$34.8M
Q3 24
$50.0M
$70.8M
Q2 24
$44.8M
Q1 24
$25.9M
Free Cash Flow
CLOV
CLOV
NESR
NESR
Q4 25
$-69.0M
Q3 25
$11.4M
$-34.1M
Q2 25
$4.8M
$68.7M
Q1 25
$-16.5M
$-9.6M
Q4 24
$33.3M
Q3 24
$49.6M
$43.4M
Q2 24
$44.4M
Q1 24
$25.5M
FCF Margin
CLOV
CLOV
NESR
NESR
Q4 25
-14.1%
Q3 25
2.3%
-11.5%
Q2 25
1.0%
21.0%
Q1 25
-3.6%
-3.2%
Q4 24
9.9%
Q3 24
15.0%
12.9%
Q2 24
12.5%
Q1 24
7.3%
Capex Intensity
CLOV
CLOV
NESR
NESR
Q4 25
0.4%
Q3 25
0.1%
13.8%
Q2 25
0.1%
9.1%
Q1 25
0.0%
9.9%
Q4 24
0.5%
Q3 24
0.1%
8.1%
Q2 24
0.1%
Q1 24
0.1%
Cash Conversion
CLOV
CLOV
NESR
NESR
Q4 25
Q3 25
0.38×
Q2 25
6.48×
Q1 25
1.97×
Q4 24
Q3 24
3.43×
Q2 24
6.04×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

NESR
NESR

Production Services$174.4M59%
Drilling And Evaluation Services$120.9M41%

Related Comparisons